美国HIV感染者亚临床动脉粥样硬化及全身免疫激活/炎症的性别差异
REPRIEVE试验纳入接受抗逆转录病毒治疗的HIV感染者,对美国部分参与者行冠状动脉CT血管造影和免疫表型分析(CTA n=755;CTA+免疫 n=725)。分析显示女性任何斑块及非钙化/易损斑块(NC/V-P)患病率较低,IL-6、hs-CRP、D-二聚体较高而Lp-PLA2较低;D-二聚体与NC/V-P的关联存在性别差异(交互P=0.055)。
要点
- 女性任何斑块患病率低于男性(RR 0.67,95%CI 0.50-0.92)。
- 女性NC/V-P患病率低于男性(RR 0.71,95%CI 0.51-1.00)。
- 女性IL-6、hs-CRP、D-二聚体较高,Lp-PLA2较低(均P<0.001)。
核心结论
- 在美国HIV感染者中,女性斑块及NC/V-P患病率较低,且关键免疫/炎症生物标志物存在差异。
- D-二聚体与斑块的关联存在性别差异,其他检测参数未见性别差异。
研究设计与样本
- REPRIEVE是一项初级ASCVD预防试验,纳入接受ART治疗的HIV感染者;美国部分参与者接受冠状动脉CTA和免疫表型分析(CTA n=755;CTA+免疫 n=725)。
- 主要分析队列包括631名男性和124名女性;除非另有说明,分析均校正ASCVD风险评分。
主要发现
- 男性ASCVD风险评分中位数4.9% vs 女性2.1%,女性肥胖率48% vs 男性21%。
- 女性任何斑块患病率较低(RR 0.67,95%CI 0.50-0.92),NC/V-P患病率较低(RR 0.71,95%CI 0.51-1.00,校正ASCVD风险评分和BMI)。
- 女性IL-6、hs-CRP、D-二聚体水平较高,Lp-PLA2较低(均P<0.001)。
- 较高Lp-PLA2、MCP-1、oxLDL与较高斑块及NC/V-P患病率相关(P<0.02),未见性别差异。
- 女性中D-二聚体与NC/V-P患病率较高相关,男性中无此关联(交互P=0.055)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Among people with HIV (PWH), sex differences in presentations of atherosclerotic cardiovascular disease (ASCVD) may be influenced by differences in coronary plaque parameters, immune/inflammatory biomarkers, or relationships therein. METHODS: REPRIEVE, a primary ASCVD prevention trial, enrolled antiretroviral therapy (ART)-treated PWH. At entry, a subset of US participants underwent coronary computed tomography angiography (CTA) and immune phenotyping (n = 755 CTA; n = 725 CTA + immune). We characterized sex differences in coronary plaque and immune/inflammatory biomarkers and compared immune-plaque relationships by sex. Unless noted otherwise, analyses adjust for ASCVD risk score. RESULTS: The primary analysis cohort included 631 males and 124 females. ASCVD risk was higher among males (median: 4.9% vs 2.1%), while obesity rates were higher among females (48% vs 21%). Prevalence of any plaque and of plaque with either ≥1 visible noncalcified portion or vulnerable features (NC/V-P) was lower among females overall and controlling for relevant risk factors (RR [95% CI] for any plaque: .67 [.50, .92]; RR for NC/V-P: .71 [.51, 1.00] [adjusted for ASCVD risk score and body mass index]). Females showed higher levels of IL-6, hs-CRP, and D-dimer and lower levels of Lp-PLA2 (P < .001 for all). Higher levels of Lp-PLA2, MCP-1, and oxLDL were associated with higher plaque (P < .02) and NC/V-P prevalence, with no differences by sex. Among females but not males, D-dimer was associated with higher prevalence of NC/V-P (interaction P = .055). CONCLUSIONS: Among US PWH, females had a lower prevalence of plaque and NC/V-P, as well as differences in key immune/inflammatory biomarkers. Immune-plaque relationships differed by sex for D-dimer but not other tested parameters. Clinical Trial Registration. ClinicalTrials.gov; identifier: NCT0234429 (date of initial registration: 22 January 2015).
引用
- Zanni MV, Foldyna B, McCallum S, et al. Sex Differences in Subclinical Atherosclerosis and Systemic Immune Activation/Inflammation Among People With Human Immunodeficiency Virus in the United States. Clin Infect Dis. 2023. PMID: 36101518. doi:10.1093/cid/ciac767
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。